PATENT CLAIM ANALYSIS

Application Number: 16119263
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "263220"]

Abstract:
The invention discloses compositions comprising BRaf inhibitors and uses thereof for treating and/or preventing by topical or systemic administration cutaneous conditions caused by treatment with EGFR inhibitors and/or PI3K inhibitors.

Claim (Index 3):
The method of  claim 1 , wherein the cutaneous condition is selected from acneiform rash, papulopustular rash, abnormal scalp hair growth, abnormal facial hair growth, abnormal hair growth, abnormal eyelash growth, paronychia with or without pyogenic granulomas and telangiectasia.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15002457', '12865620', '14147689', '14770994', '15105904']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7633299827039892
- 35 USC 102 Novelty (BERT): 0.5325779629302023
- Combined Prediction Score: 0.7402547807266106
- Mean Citation Score: 302.35572
- Max Citation Score: 316.7195700000001
- Similarity Product: 191.94839081651327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test